Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease (COPD), Coronary Artery Disease, Diabete Mellitus, Heart Failure, Hyperlipidemia, Hypertension, Obesity &Amp; Overweight, Stroke
Conditions
Brief summary
The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims to address is: Does polypharmacy affect the prognosis of elderly patients with chronic diseases? Elderly patients with chronic diseases will be asked to complete online survey questions regarding their disease prognosis over a 2-year period.
Interventions
None listed
Sponsors
Xijing Hospital
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged 65 years or older with at least one chronic disease
Exclusion criteria
* Patients without chronic diseases * Patients refused to participate in the study * Patients with unstable vital signs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessing the current status of polypharmacy in elderly patients with chronic diseases in Shaanxi Province via cluster sampling questionnaire survey | Start from enrollment to the end of the study at 2 years. | A cluster sampling method was used to conduct a survey on elderly patients with chronic diseases in Shaanxi Province. A questionnaire survey was conducted in different regional locations to collect detailed medication information from patients, such as the number of chronic diseases (types), the types of medications used (types), specific drug names, medication costs (yuan), and duration of medication use (months). Medication habits, such as whether the medication is prescribed by a hospital, purchased from a pharmacy, recommended by friends, or promoted through advertisements, etc. Specific items include concerns about drugs and current physical discomforts. A 5-point Likert scale was adopted, where 1 point indicates strongly disagree and 5 points indicate strongly agree. After questionnaire collection, combined with Beers, STOPP/START, and Chinese elderly PIM criteria, a polypharmacy evaluation and management strategy for these patients was developed. |
Countries
China
Contacts
Primary ContactMing Yuan, MD, PhD
Outcome results
None listed